Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended July 1, 2017. Second Quarter Financial ...
IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter 2017 after the close of trading...
IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Ann Rhoads to the Company's Board of Directors, Audit Committee, and...
IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Jefferies 2017 Global Healthcare Conference in New ...
IRIDEX Corporation (Nasdaq: IRIX) today announced the presentation of data demonstrating the safety and efficacy of its proprietary MicroPulse®...
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months ended April 1, 2017. Recent Financial Results and Highlights...
IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the first quarter 2017 after the close of trading on...
IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the Sidoti & Co. Spring 2017 Convention in New York, NY....
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months and full year ended December 31, 2016 and provided its full...
IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the 29th Annual Roth Conference in Orange County, CA. Iridex's...
IRIDEX Corporation (Nasdaq: IRIX) is pleased to announce the availability of the G-Probe™ Illuminate, a new, FDA-cleared probe offering combined...
IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the fourth quarter and 2016 after the close of trading...
IRIDEX Corporation (Nasdaq: IRIX) today reported preliminary revenues of approximately $12.4 to $12.5 million and $46.0 to $46.1 million for the...
IRIDEX Corporation (NASDAQ: IRIX) today announced the pricing of its underwritten public offering of an aggregate of 1.15 million shares of common...
IRIDEX Corporation (NASDAQ: IRIX) today announced that it intends to offer newly issued shares of common stock, $0.01 par value (the "Offering" with...
IRIDEX Corporation (NASDAQ: IRIX) today announced that management is scheduled to present at the following investor conferences in New York City: The ...
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended October 1, 2016. Revenues were $9.8...
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its third quarter 2016 financial results after the market closes on Thursday,...
IRIDEX Corporation (Nasdaq: IRIX) today reported preliminary revenues of approximately $9.6 to $9.7 million for the third quarter ended October 1,...
IRIDEX Corporation (Nasdaq:IRIX), a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today...
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its second quarter 2016 financial results after the market closes on Thursday, ...
IRIDEX Corporation (Nasdaq: IRIX) today announced that Atabak Mokari, 39, will join the Company as Chief Financial Officer and Vice President of...
IRIDEX Corporation (Nasdaq: IRIX), a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today...
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 2, 2016. Revenues were $11.9 million for the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.